Evolution of 𝜷-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation
Diabetes mellitus remains one of the leading causes of morbidity and mortality worldwide. According to the Centers for Disease Control and Prevention, approximately 23.6 million people in the United States are affected. Of these individuals, 5 to 10% have been diagnosed with Type 1 diabetes mellitus...
Saved in:
Main Authors: | Cyrus Jahansouz, Cameron Jahansouz, Sean C. Kumer, Kenneth L. Brayman |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Journal of Transplantation |
Online Access: | http://dx.doi.org/10.1155/2011/247959 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
B7-H4 Pathway in Islet Transplantation and β-Cell Replacement Therapies
by: Xiaojie Wang, et al.
Published: (2011-01-01) -
Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem Cells
by: Nadine E. Rekittke, et al.
Published: (2016-01-01) -
In Vitro Proliferation of Porcine Pancreatic Islet Cells for β-Cell Therapy Applications
by: Guoguang Niu, et al.
Published: (2016-01-01) -
Islet Cell Biology, Regeneration, and Transplantation
by: A. N. Balamurugan, et al.
Published: (2012-01-01) -
Regeneration of Pancreatic β-Islet Cells in a Type-II Diabetic
by: Edwin C. Jones, et al.
Published: (2018-01-01)